Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    17241859 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Safety and Tolerability of FITC-Adalimumab Administration During Confocal Laser Endomicroscopy of the Gut
Condition: Crohn's Disease
Intervention: Drug: FITC-Adalimumab
2 Not yet recruiting Pediatric Crohn's Disease AdalImumab Level-based Optimization Treatment (PAILOT) Trial
Condition: Crohn's Disease
Intervention: Drug: Adalimumab

Indicates status has not been verified in more than two years